APC and neoplasm: High miR-19a expression correlates with elevated β-catenin levels and advanced tumor stages in CRC specimens, suggesting that targeting the miR-17-92 cluster may have therapeutic potential in colon cancers with abnormal APC/β-catenin signaling.